TON - April 2013, Vol 6, No 3

About 3% to 5% of the general population is believed to have a mutation in the gene that encodes a major 5-fluorouracil (5-FU) metabolizing enzyme. Read More ›

Nurse Navigators and the Continuum of Care Read More ›

A pproximately 2350 urologists, oncologists, surgeons, radiation oncologists, and other oncology healthcare professionals gathered in Orlando, Florida, to attend the 2013 Genitourinary Cancers Symposium. Read More ›

Hand-foot skin reaction (HFSR), also known as hand-foot syndrome or palmar-plantar erythrodysesthesia (PPE), is an adverse effect of several chemotherapeutic agents. Read More ›

This issue of The Oncology Nurse-APN/PA (TON) is packed with news about what is happening in the world of oncology research and brings you information that helps you in your day-to-day practice. We highlight news from the 2013 Genitourinary Cancers Symposium and the Hematology/Oncology Pharmacy Association (HOPA) 9th Annual Conference. Read More ›

Testicular cancer, or testis cancer, is most often found in young men. With the use of surgery, radiation therapy, and/or chemotherapy, this type of cancer is highly treatable, and it is often curable. Read More ›

According to a retrospective review of more than 13,000 cases, most women with ovarian cancer received substandard care that significantly reduced their survival odds. Read More ›